(Date:11/20/2009)...n American countries have an opportunity to take t...chers from the University of Valencia (UV), workin...ed the productive fabric of the Spanish biotechnol...d and plant sectors have more clout than those in ...pplied to food and plants has been overlooked by t...
(Date:11/20/2009)...EATTLE, Nov. 20 Cell The...nced today that the Ninth Circuit Court of Appeals...at CTI should be allowed to pursue all of its clai...o the District Court for trial. CTI filed a compl...rty reimbursement consultant for CTI,s product TRI...
(Date:11/19/2009)...LE, Nov. 19 Omeros Corpo...financial results for the third quarter ended Sept...er 30, 2009, Omeros reported a net loss of $3.9 mi...ss of $7.4 million, or $2.54 per share, for the sa...mber 30, 2009, the Company reported a net loss of ...
(Date:11/19/2009)...ALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswir...on Resources find that the leading driver of antib...is broad-spectrum activity against gram-positive a...organisms that can cause nosocomial pneumonia, sur...imarily for agents that provide appropriate covera...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3...ms and rivers, affecting the number and variety of...niversity study has found. , Rivers and streams a...m important links with surrounding habitats, yet l...ical effects of climate change on these running-wa...Brianne in central Wales, led by Professor Steve O...
...nt the immune system from launching an all-out fig...ity of a nutrient "floodgate" that serves to prote...heir findings appear in the May 4, 2007 issue of t...e researchers found that animals lacking a protein...te inflammation in deep pockets of visceral fat. T...
...are ridding diabetic patients of the superbug MRSA...rofessor Andrew Boulton and his team used green bo...e foot ulcers were contaminated with MRSA and foun...hree weeks, much quicker than the 28-week duration...ulton, who published the results in the journal Di...
Other Biology News:Keeping the immune system from starting a 'food fight' 2Maggots rid patients of MRSA 2Mouse Anti-Cohesin (Scc1 / Rad21) Monoclonal Antibody, Unconjugated, Clone CM110-2C10 from MBL International
Chicken Anti-Human Proline-serine-threonine phosphatase-interacting protein 2 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Mouse Anti-Human gamma Glutamyl Transferase (gammaGT) Monoclonal Antibody, Unconjugated from AnaSpec
...to Cholesterol Oxidase Immunogen Cholesterol Oxi...ross-reacts with bacteria. Not yet tested in other...dases exist as both type I and type II oxidases an...ition, they are important as clinical reagents, po...
Biology Products: